{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:20:12Z","timestamp":1788373212975,"version":"build-2803163510"},"reference-count":119,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014989","name":"The Chan Zuckerberg Initiative","doi-asserted-by":"publisher","award":["CZF2019-002449"],"award-info":[{"award-number":["CZF2019-002449"]}],"id":[{"id":"10.13039\/100014989","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["K25HL157603"],"award-info":[{"award-number":["K25HL157603"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01HG011345"],"award-info":[{"award-number":["1R01HG011345"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01HG012079"],"award-info":[{"award-number":["U01HG012079"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2R01HG006399"],"award-info":[{"award-number":["2R01HG006399"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM150822"],"award-info":[{"award-number":["R35GM150822"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01ES029929"],"award-info":[{"award-number":["R01ES029929"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH125252"],"award-info":[{"award-number":["R01MH125252"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH122688"],"award-info":[{"award-number":["R01MH122688"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Genomics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.xgen.2024.100722","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T10:38:32Z","timestamp":1733308712000},"page":"100722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Characterizing the genetic architecture of drug response using gene-context interaction methods"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5998-0432","authenticated-orcid":false,"given":"Michal","family":"Sadowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Mefford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanushree","family":"Haldar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinyemi","family":"Oni-Orisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Border","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Pazokitoroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien F.","family":"Ayroles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriram","family":"Sankararaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy W.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Zaitlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xgen.2024.100722_bib1","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM200105033441802","article-title":"Lesser Response to Angiotensin-Converting\u2013Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular Dysfunction","volume":"344","author":"Exner","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib2","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2010.1543","article-title":"Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI: A Meta-analysis","volume":"304","author":"Mega","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.xgen.2024.100722_bib3","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/ng.3677","article-title":"Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy","volume":"48","author":"Riaz","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-genom-090413-025419","article-title":"Personalized Pharmacogenomics: Predicting Efficacy and Adverse Drug Reactions","volume":"15","author":"Pirmohamed","year":"2014","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1471-4914(01)01986-4","article-title":"Clinical application of pharmacogenetics","volume":"7","author":"Spear","year":"2001","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib6","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of Adverse Drug Reactions in Hospitalized PatientsA Meta-analysis of Prospective Studies","volume":"279","author":"Lazarou","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.xgen.2024.100722_bib7","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa012113","article-title":"Genetic Testing","volume":"347","author":"Burke","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature02626","article-title":"Moving towards individualized medicine with pharmacogenomics","volume":"429","author":"Evans","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.xgen.2024.100722_bib9","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMsb1503104","article-title":"Precision Medicine \u2014 Personalized, Problematic, and Promising","volume":"372","author":"Jameson","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.2020.1406","article-title":"Integrating Personalized Medicine With Population Health Management: The Path Forward","volume":"324","author":"Grossman","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.xgen.2024.100722_bib11","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra032424","article-title":"Drug Metabolism and Variability among Patients in Drug Response","volume":"352","author":"Wilkinson","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib12","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(02)11203-7","article-title":"Clinical importance of the cytochromes P450","volume":"360","author":"Nebert","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.xgen.2024.100722_bib13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 Variants and Statin-Induced Myopathy \u2014 A Genomewide Study","volume":"359","author":"Link","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa0708078","article-title":"Genetic Determinants of Response to Warfarin during Initial Anticoagulation","volume":"358","author":"Schwarz","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B\u22175701 Screening for Hypersensitivity to Abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib16","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A\u22173101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib17","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","article-title":"Carbamazepine-Induced Toxic Effects and HLA-B\u22171502 Screening in Taiwan","volume":"364","author":"Chen","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib18","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","article-title":"Adjuvant olaparib for patients with BRCA1-or BRCA2-mutated breast cancer","volume":"384","author":"Tutt","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib20","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMoa1311386","article-title":"A Randomized Trial of Genotype-Guided Dosing of Warfarin","volume":"369","author":"Pirmohamed","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib21","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(12)60161-5","article-title":"Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial","volume":"379","author":"Roberts","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.xgen.2024.100722_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(22)01841-4","article-title":"A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study","volume":"401","author":"Swen","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.xgen.2024.100722_bib23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/jamaneurol.2018.0278","article-title":"Association of HLA-A\u221731:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population","volume":"75","author":"Mushiroda","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.xgen.2024.100722_bib24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41576-022-00572-8","article-title":"Pharmacogenomics: current status and future perspectives","volume":"24","author":"Pirmohamed","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrg.2016.12","article-title":"The genetics of drug efficacy: opportunities and challenges","volume":"17","author":"Nelson","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/clpt.2010.279","article-title":"CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network","volume":"89","author":"Relling","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.xgen.2024.100722_bib27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.2009.1232","article-title":"Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy","volume":"302","author":"Shuldiner","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.xgen.2024.100722_bib28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41397-018-0040-6","article-title":"Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis","volume":"18","author":"Massey","year":"2018","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.xgen.2024.100722_bib29","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2217\/pgs-2021-0108","article-title":"The need to shift pharmacogenetic research from candidate gene to genome-wide association studies","volume":"22","author":"Linskey","year":"2021","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.xgen.2024.100722_bib30","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/cpt.2323","article-title":"Genome-Wide Approach to Measure Variant-Based Heritability of Drug Outcome Phenotypes","volume":"110","author":"Muhammad","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.xgen.2024.100722_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042921-112629","article-title":"Advances and Applications of Polygenic Scores for Coronary Artery Disease","volume":"74","author":"Patel","year":"2023","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41569-021-00638-w","article-title":"Clinical utility of polygenic risk scores for coronary artery disease","volume":"19","author":"Klarin","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.xgen.2024.100722_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/jamapsychiatry.2020.3049","article-title":"From Basic Science to Clinical Application of Polygenic Risk Scores: A Primer","volume":"78","author":"Wray","year":"2021","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.xgen.2024.100722_bib34","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/s41591-022-01767-6","article-title":"Development of a clinical polygenic risk score assay and reporting workflow","volume":"28","author":"Hao","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib35","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41591-021-01549-6","article-title":"Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps","volume":"27","author":"Adeyemo","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib36","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","article-title":"Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes","volume":"104","author":"Mavaddat","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib38","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","article-title":"Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease","volume":"375","author":"Khera","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib39","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1161\/ATVBAHA.120.314856","article-title":"Genome-Wide Polygenic Score, Clinical Risk Factors, and Long-Term Trajectories of Coronary Artery Disease","volume":"40","author":"Hindy","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.xgen.2024.100722_bib40","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.007012","article-title":"Polygenic Score for \u03b2-Blocker Survival Benefit in European Ancestry Patients With Reduced Ejection Fraction Heart Failure","volume":"13","author":"Lanfear","year":"2020","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.xgen.2024.100722_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.121.003835","article-title":"Validation of a Polygenic Score for Beta-Blocker Survival Benefit in Patients With Heart Failure Using the United Kingdom Biobank","volume":"16","author":"Lanfear","year":"2023","journal-title":"Circ Genom Precis Med."},{"key":"10.1016\/j.xgen.2024.100722_bib42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/cpt.2957","article-title":"An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers","volume":"114","author":"Oni-Orisan","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.xgen.2024.100722_bib43","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMp1904511","article-title":"Has the Genome Granted Our Wish Yet?","volume":"380","author":"Hunter","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib44","first-page":"65","article-title":"Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study","volume":"75","author":"Amare","year":"2018","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.xgen.2024.100722_bib45","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1176\/appi.ajp.22010045","article-title":"Association Between Polygenic Risk Scores and Outcome of ECT","volume":"179","author":"Sigstr\u00f6m","year":"2022","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.xgen.2024.100722_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.117.002043","article-title":"Characterization of Statin Low-Density Lipoprotein Cholesterol Dose-Response Using Electronic Health Records in a Large Population-Based Cohort","volume":"11","author":"Oni-Orisan","year":"2018","journal-title":"Circ Genom Precis Med."},{"key":"10.1016\/j.xgen.2024.100722_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41525-019-0109-4","article-title":"The impact of adjusting for baseline in pharmacogenomic genome-wide association studies of quantitative change","volume":"5","author":"Oni-Orisan","year":"2020","journal-title":"NPJ Genom. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib48","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.abo2059","article-title":"Cross-trait assortative mating is widespread and inflates genetic correlation estimates","volume":"378","author":"Border","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.xgen.2024.100722_bib49","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.xgen.2024.100722_bib50","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2022.12138","article-title":"Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"328","author":"Chou","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.xgen.2024.100722_bib51","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.xgen.2024.100722_bib52","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.2337\/dc13-2215","article-title":"Statins and the Risk of Diabetes: Evidence From a Large Population-Based Cohort Study","volume":"37","author":"Corrao","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xgen.2024.100722_bib53","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy: A Meta-analysis","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.xgen.2024.100722_bib54","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.xgen.2024.100722_bib55","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.xgen.2024.100722_bib56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-128-3-199802010-00001","article-title":"United Kingdom Prospective Diabetes Study 24: A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients with Newly Diagnosed Type 2 Diabetes That Could Not Be Controlled with Diet Therapy","volume":"128","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib57","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/M15-2650","article-title":"Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis","volume":"164","author":"Maruthur","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","article-title":"Low-dose metformin targets the lysosomal AMPK pathway through PEN2","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xgen.2024.100722_bib59","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/db06-0918","article-title":"Factors Associated With Diabetes Onset During Metformin Versus Placebo Therapy in the Diabetes Prevention Program","volume":"56","author":"Lachin","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.xgen.2024.100722_bib60","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","article-title":"GDF15 mediates the effects of metformin on body weight and energy balance","volume":"578","author":"Coll","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xgen.2024.100722_bib61","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJM199508313330902","article-title":"Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus","volume":"333","author":"DeFronzo","year":"1995","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib62","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.4254\/wjh.v7.i12.1652","article-title":"Systematic review: Preventive and therapeutic applications of metformin in liver disease","volume":"7","author":"Bhat","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.xgen.2024.100722_bib63","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00008571-200305000-00002","article-title":"Pharmacogenetics of oral anticoagulants","volume":"13","author":"Daly","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.xgen.2024.100722_bib64","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0002-9343(93)90285-W","article-title":"Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention","volume":"95","author":"Landefeld","year":"1993","journal-title":"Am. J. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1067\/mcp.2001.117444","article-title":"Interindividual variability in sensitivity to warfarin-Nature or nurture?","volume":"70","author":"Loebstein","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.xgen.2024.100722_bib66","first-page":"q","article-title":"Methotrexate for treating rheumatoid arthritis","volume":"q","author":"Lopez-Olivo","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.xgen.2024.100722_bib67","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/ard.2008.093690","article-title":"Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research","volume":"68","author":"Salliot","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.xgen.2024.100722_bib68","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ajhg.2019.11.015","article-title":"A Robust Method Uncovers Significant Context-Specific Heritability in Diverse Complex Traits","volume":"106","author":"Dahl","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib69","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/ng.3367","article-title":"A gene-based association method for mapping traits using reference transcriptome data","volume":"47","author":"Gamazon","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib70","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng.3506","article-title":"Integrative approaches for large-scale transcriptome-wide association studies","volume":"48","author":"Gusev","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib71","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/jamapsychiatry.2014.1339","article-title":"Correcting Systematic Inflation in Genetic Association Tests That Consider Interaction Effects: Application to a Genome-wide Association Study of Posttraumatic Stress Disorder","volume":"71","author":"Almli","year":"2014","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.xgen.2024.100722_bib72","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/bioinformatics\/btw198","article-title":"TreeQTL: hierarchical error control for eQTL findings","volume":"32","author":"Peterson","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xgen.2024.100722_bib73","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/gepi.21942","article-title":"Many Phenotypes Without Many False Discoveries: Error Controlling Strategies for Multitrait Association Studies","volume":"40","author":"Peterson","year":"2016","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.xgen.2024.100722_bib74","doi-asserted-by":"crossref","first-page":"D977","DOI":"10.1093\/nar\/gkac1010","article-title":"The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource","volume":"51","author":"Sollis","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xgen.2024.100722_bib75","doi-asserted-by":"crossref","first-page":"D712","DOI":"10.1093\/nar\/gkq1156","article-title":"ConsensusPathDB: toward a more complete picture of cell biology","volume":"39","author":"Kamburov","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xgen.2024.100722_bib76","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41588-019-0367-1","article-title":"Probabilistic fine-mapping of transcriptome-wide association studies","volume":"51","author":"Mancuso","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib77","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1055\/s-2004-826162","article-title":"Physiology of GIP - A Lesson from GIP Receptor Knockout Mice","volume":"36","author":"Yamada","year":"2004","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.xgen.2024.100722_bib78","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/tpj.2011.28","article-title":"Association between the GIPR gene and the insulin level after glucose loading in schizophrenia patients treated with olanzapine","volume":"12","author":"Ono","year":"2012","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.xgen.2024.100722_bib79","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.3390\/ijms21197153","article-title":"A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis Patients","volume":"21","author":"Ogawa","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xgen.2024.100722_bib80","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/mrd.23047","article-title":"ITGA1 is upregulated in response to oxygen over time in a BMP4 model of trophoblast","volume":"85","author":"Karvas","year":"2018","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.xgen.2024.100722_bib81","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41586-019-1879-7","article-title":"A brief history of human disease genetics","volume":"577","author":"Claussnitzer","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xgen.2024.100722_bib82","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.ajhg.2021.07.008","article-title":"A polygenic-score-based approach for identification of gene-drug interactions stratifying breast cancer risk","volume":"108","author":"Marderstein","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib83","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/CIRCULATIONAHA.108.773267","article-title":"Alternative Splicing of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Is Associated With Plasma Low-Density Lipoprotein Cholesterol Response to Simvastatin","volume":"118","author":"Medina","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.xgen.2024.100722_bib84","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11883-016-0604-3","article-title":"Statins and Their Effect on PCSK9\u2014Impact and Clinical Relevance","volume":"18","author":"Taylor","year":"2016","journal-title":"Curr. Atherosclerosis Rep."},{"key":"10.1016\/j.xgen.2024.100722_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173114","article-title":"Statins and PCSK9 inhibitors: A new lipid-lowering therapy","volume":"878","author":"Gallego-Colon","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.xgen.2024.100722_bib86","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","article-title":"Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes","volume":"375","author":"Ference","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xgen.2024.100722_bib87","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tibs.2006.12.008","article-title":"Molecular biology of PCSK9: its role in LDL metabolism","volume":"32","author":"Horton","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.xgen.2024.100722_bib88","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/tpj.2016.3","article-title":"The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy","volume":"17","author":"Feng","year":"2017","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.xgen.2024.100722_bib89","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13293-024-00602-6","article-title":"Sex and statin-related genetic associations at the PCSK9 gene locus: results of genome-wide association meta-analysis","volume":"15","author":"Pott","year":"2024","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.xgen.2024.100722_bib90","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48376","article-title":"Variable prediction accuracy of polygenic scores within an ancestry group","volume":"9","author":"Mostafavi","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.xgen.2024.100722_bib91","article-title":"Amplification is the primary mode of gene-by-sex interaction in complex human traits","volume":"3","author":"Zhu","year":"2023","journal-title":"Cell Genom."},{"key":"10.1016\/j.xgen.2024.100722_bib92","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajhg.2021.11.008","article-title":"Portability of 245 polygenic scores when derived from the UK Biobank and applied to 9 ancestry groups from the same cohort","volume":"109","author":"Priv\u00e9","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib93","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","article-title":"Clinical use of current polygenic risk scores may exacerbate health disparities","volume":"51","author":"Martin","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib94","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.ajhg.2024.05.015","article-title":"A scalable and robust variance components method reveals insights into the architecture of gene-environment interactions underlying complex traits","volume":"111","author":"Pazokitoroudi","year":"2024","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib95","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/ajcp\/107.6.672","article-title":"Performance of Prothrombin-Proconvertin Time as a Monitoring Test of Oral Anticoagulation Therapy","volume":"107","author":"Magn\u00fas Haraldsson","year":"1997","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.xgen.2024.100722_bib96","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clpt.2005.11.011","article-title":"Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements","volume":"79","author":"Aquilante","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.xgen.2024.100722_bib97","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s41588-020-0706-2","article-title":"A unified framework for joint-tissue transcriptome-wide association and Mendelian randomization analysis","volume":"52","author":"Zhou","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib98","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1038\/s41467-022-33212-0","article-title":"Multi-context genetic modeling of transcriptional regulation resolves novel disease loci","volume":"13","author":"Thompson","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xgen.2024.100722_bib99","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41588-019-0345-7","article-title":"A statistical framework for cross-tissue transcriptome-wide association analysis","volume":"51","author":"Hu","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13059-020-1942-6","article-title":"A framework for transcriptome-wide association studies in breast cancer in diverse study populations","volume":"21","author":"Bhattacharya","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.xgen.2024.100722_bib101","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ajhg.2018.06.002","article-title":"Estimating SNP-Based Heritability and Genetic Correlation in Case-Control Studies Directly and with Summary Statistics","volume":"103","author":"Weissbrod","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009763","article-title":"Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations","volume":"5","author":"Barber","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.xgen.2024.100722_bib103","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCGENETICS.111.961144","article-title":"Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial","volume":"5","author":"Chasman","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib104","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1194\/jlr.P021113","article-title":"Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)","volume":"53","author":"Deshmukh","year":"2012","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.xgen.2024.100722_bib105","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1038\/ncomms6068","article-title":"Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins","volume":"5","author":"Postmus","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xgen.2024.100722_bib106","series-title":"Exploring Network Structure, Dynamics, and Function Using NetworkX","author":"Hagberg","year":"2008"},{"key":"10.1016\/j.xgen.2024.100722_bib107","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1093\/bioinformatics\/bty185","article-title":"Efficient analysis of large-scale genome-wide data with two R packages: bigstatsr and bigsnpr","volume":"34","author":"Priv\u00e9","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xgen.2024.100722_bib108","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1534\/genetics.119.302019","article-title":"Efficient Implementation of Penalized Regression for Genetic Risk Prediction","volume":"212","author":"Priv\u00e9","year":"2019","journal-title":"Genetics"},{"key":"10.1016\/j.xgen.2024.100722_bib109","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ajhg.2010.11.011","article-title":"GCTA: A Tool for Genome-wide Complex Trait Analysis","volume":"88","author":"Yang","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib110","first-page":"1","article-title":"Various versatile variances: an object-oriented implementation of clustered covariances in R","volume":"95","author":"Zeileis","year":"2020","journal-title":"J.\u00a0Stat. Software"},{"key":"10.1016\/j.xgen.2024.100722_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v011.i10","article-title":"Econometric Computing with HC and HAC Covariance Matrix Estimators","volume":"11","author":"Zeileis","year":"2004","journal-title":"J Statistical Software"},{"key":"10.1016\/j.xgen.2024.100722_bib112","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.xgen.2024.100722_bib113","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.1262110","article-title":"The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans","volume":"348","author":"Ardlie","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.xgen.2024.100722_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0307270","article-title":"A systematic evaluation of the performance and properties of the UK Biobank Polygenic Risk Score (PRS) Release","volume":"19","author":"Thompson","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.xgen.2024.100722_bib115","article-title":"Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study","volume":"10","author":"Yuan","year":"2021","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.xgen.2024.100722_bib116","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ajhg.2021.02.014","article-title":"Estimation of non-additive genetic variance in human complex traits from a large sample of unrelated individuals","volume":"108","author":"Hivert","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib117","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/aje\/kwr368","article-title":"Gene-Environment Interactions in Genome-Wide Association Studies: A Comparative Study of Tests Applied to Empirical Studies of Type 2 Diabetes","volume":"175","author":"Cornelis","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.xgen.2024.100722_bib118","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/EDE.0b013e31820877c5","article-title":"On the Robustness of Tests of Genetic Associations Incorporating Gene-environment Interaction When the Environmental Exposure is Misspecified","volume":"22","author":"Tchetgen","year":"2011","journal-title":"Epidemiology"},{"key":"10.1016\/j.xgen.2024.100722_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003486","article-title":"A Statistical Framework for Joint eQTL Analysis in Multiple Tissues","volume":"9","author":"Flutre","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.xgen.2024.100722_bib120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006423","article-title":"Survey of the Heritability and Sparse Architecture of Gene Expression Traits across Human Tissues","volume":"12","author":"Wheeler","year":"2016","journal-title":"PLoS Genet."}],"container-title":["Cell Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666979X24003513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666979X24003513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T23:35:58Z","timestamp":1734046558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666979X24003513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":119,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2666979X24003513"],"URL":"https:\/\/doi.org\/10.1016\/j.xgen.2024.100722","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.03.29.24305093","asserted-by":"object"}]},"ISSN":["2666-979X"],"issn-type":[{"value":"2666-979X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing the genetic architecture of drug response using gene-context interaction methods","name":"articletitle","label":"Article Title"},{"value":"Cell Genomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xgen.2024.100722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100722"}}